A recent bipartisan Senate hearing exposed critical gaps in menopause research, clinical training, and patient access for midlife women's health in the U.S.
On September 16, 2026, the U.S. Senate Special Committee on Aging held what lawmakers described as Congress’s first hearing devoted to menopause. The bipartisan session reviewed major gaps in clinical education, research funding, and patient access to care.
Historically, the standard medical approach to menopause left many women navigating profound physical changes without adequate clinical support. Routine gynecological and primary care appointments heavily prioritized reproductive health, fertility, and pregnancy. Menopause symptoms, from shifting metabolism to painful intercourse and changing physical desire, were frequently dismissed as inevitable consequences of aging.
Before this national conversation gained traction, the default medical model essentially ignored the post-reproductive years. Gynecologists were largely trained to manage fertility, pregnancy, and acute pelvic disease. Primary care physicians were trained to manage cardiovascular risk, diabetes, and infectious disease. Neither specialty was explicitly tasked with managing the complex, systemic shifts that occur during perimenopause and menopause.
This structural blind spot meant that millions of women entered their midlife years without a dedicated medical advocate. Patients seeking help for sexual pain, sleep disruption, or changing body composition routinely found that their doctors lacked specific training. This fragmented clinical model placed the heavy burden entirely on the patient to find specialized help or simply tolerate discomfort. Women were expected to manage hot flashes, mood shifts, and complex genitourinary symptoms without expecting structural medical support from their healthcare providers.
Medical education itself reinforced this gap by dedicating very few hours to the menopausal transition. Doctors often graduated with a deep understanding of obstetrics but minimal practical knowledge of how changing hormones affect a woman's cardiovascular, metabolic, and sexual health. Consequently, the clinical consensus silently accepted that women would simply age out of active medical intervention.
The hearing, titled “Half the Country, Zero Hearings,” brought national attention to the specific ways the medical system underserves midlife women. Lawmakers and medical professionals outlined a series of structural failures affecting research, access, and clinical education across the United States.
The lack of dedicated financial resources creates a severe bottleneck for medical innovation. When less than 1 percent of federal research funding targets menopause, scientists struggle to run large-scale studies on long-term physical outcomes. This lack of data makes it harder to develop new treatments for women experiencing disruptive physical symptoms.
Without robust clinical trials, doctors are left relying on older observational data that may not reflect modern medical standards. This research gap directly translates to a care gap in the examination room. If federal agencies do not prioritize midlife women's health, universities and pharmaceutical companies are less likely to invest in solving these complex medical challenges.
The economic ripple effects of this medical care gap are substantial and widely felt. Women experiencing severe sleep disruption, debilitating hot flashes, or profound mood changes often find themselves struggling to maintain their professional momentum without appropriate medical intervention. The lack of a federal workplace law leaves employees to navigate these physical challenges entirely on their own.
The proposed $25 million annual authorization represents a significant potential shift in how the government values women's health. While it remains a proposal rather than enacted policy, it signals a growing recognition that midlife health requires serious financial backing. Investing in research is the only way to build a reliable, evidence-based foundation for clinical care. Connecting these broad policy shifts to perimenopause and menopause resources helps women track how the medical landscape is actively evolving.
The testimony provided a stark view of the clinical realities midlife women face today. Gynecologist Suzanne Fenske told the committee that her own obstetrics and gynecology core curriculum included very little menopause training. Her education focused mainly on reproductive issues and pregnancy, leaving her to seek out additional knowledge on her own time.
This lack of structured training has direct, negative consequences for patient quality of life. Lynne Coslett-Charlton, representing the American College of Obstetricians and Gynecologists, argued that women should not have to simply endure difficult symptoms. She stated that the goal should be to help women thrive, maintain independence, and feel well as they age.
Coslett-Charlton noted that appropriate therapies can improve quality of life, provide preventive health benefits, and reduce debilitating physical symptoms. She also stressed that access to high-quality menopause care should not depend on a patient's financial circumstances. Senator Kirsten Gillibrand highlighted the historical neglect of the issue during her remarks, stating, "Women have carried this alone for generations. Not anymore."
Sexual wellbeing is a core component of midlife health that often remains unaddressed in standard medical appointments. Midlife patients frequently seek help for vaginal dryness, genital discomfort, painful intercourse, and shifts in physical desire. The hearing highlighted how limited training and uneven access to treatment leave many women without clear clinical answers.
When doctors lack specific menopause education, patients might mistakenly assume that sexual pain is an untreatable part of getting older. Assessment by a knowledgeable clinician is necessary to determine if symptoms stem from genitourinary changes, pelvic-floor problems, dermatologic conditions, or medication side effects. Reviewing reliable sexual wellbeing resources can provide a helpful baseline before scheduling a specialized appointment.
The current medical system often fails to differentiate between temporary discomfort and chronic genitourinary conditions that require ongoing medical intervention. Advocacy for better access and training helps bring these quiet struggles into the light of formal medical review. Midlife women deserve thorough clinical evaluations rather than quick dismissals when discussing their intimate health.
The hearing made it clear that better access to care does not mean every patient requires the exact same treatment plan. Menopause symptoms are incredibly heterogeneous across different patient populations. Sexual discomfort, mood changes, low desire, fatigue, and sleep disruption may share common triggers, but they often involve entirely different underlying physical causes. Stress, relationship factors, and other concurrent health conditions can significantly complicate a patient's physical presentation.
These overlapping symptoms require careful, individualized medical evaluation rather than broad assumptions about aging. This complex symptom overlap shows why women need access to well-trained professionals who can evaluate the full clinical picture. A single treatment plan does not offer a universal, risk-free fix for every midlife physical change.
Assessment by a knowledgeable clinician is necessary to determine the true root cause of changing health dynamics. Reading evidence-based articles on sexual wellbeing can help women distinguish between temporary physical adjustments and longer-term structural shifts. True personalized care means matching the specific medical intervention to the individual woman's precise health profile.
The bipartisan attention on this medical care gap suggests that women do not have to quietly accept a lack of clinical support. Senator Rick Scott noted that the hearing was not intended to produce a one-size-fits-all solution, but to make certain that women could access good information, appropriate providers, and viable treatment options. Patients can take practical steps to secure better guidance right now.
First, it is entirely appropriate for patients to ask clinicians about their specific menopause training background before booking an appointment. Women can politely inquire whether a provider routinely assesses genitourinary symptoms, metabolic shifts, and bone health in midlife patients. If a routine appointment yields dismissal or unhelpful advice, seeking a qualified menopause specialist or a pelvic-floor physical therapist is a highly logical next step. For those looking to understand these dynamics further, Refemina's health articles offer clear context on how changing hormones intersect with whole-body health.
Second, a useful medical appointment should cover far more than acute hot flashes and missed periods. Women have every right to raise questions about painful sex, urinary frequency, changes in desire, and shifting physical strength. Addressing these overlapping concerns helps clinicians build a much more accurate and effective long-term care plan. Bringing a written list of physical changes to the appointment can help keep the conversation focused on measurable health outcomes.
Finally, the legislative discussion reinforces the reality that treatment decisions must be highly individualized. While the proposed annual authorization represents a potential federal investment in vital research, it is not yet enacted law. Until systemic changes materialize, women must navigate a fragmented medical system by seeking out reliable clinical information and practitioners who treat them as capable adults.
This legislative spotlight shifts menopause care from a silent, individual burden into a recognized, multidisciplinary clinical standard that prioritizes lifelong physical capacity.
Sorting through conflicting information about perimenopause, menopause and postmenopause makes navigating an already fragmented medical system significantly more difficult for midlife patients. Refemina translates credible clinical evidence into clear adult guidance, helping women address shifting body composition, nutrition, and intimate confidence without falling back on symptom panic or aggressive anti-aging marketing.
Follow Refemina for research-led insights on menopause, strength, metabolism, nutrition, skin, intimacy and confidence through midlife. New articles turn complex topics into clear, useful context.
Keep learning about the changes that shape energy, strength, confidence and wellbeing through midlife.
Explore Resources